Autoantibody Positive
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk" (NCT01030861) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2010-08-01 |
Track Autoantibody Positive automatically
Every clearance here is in the API, with alerts when new ones post.